8Transitional arrangements

8  Transitional arrangements

 (1) In this section:

  former specification means the instrument specified in Schedule 2, as in force immediately before the commencement of this instrument.

  transition period, for a medicine in a prescribed class, means the period beginning on the commencement of this instrument, and ending on 31 August 2020.

 (2) Despite the repeal of the former specification in section 9 of this instrument, that specification continues to apply for the duration of the transition period in relation to the classes of medicines prescribed for the purposes of paragraph 3(5)(ca) of the Act, such that the advisory statements specified in the former specification may continue to be used on a label of a medicine, as an alternative to the advisory statements specified under section 7 of this instrument.

Note:  During the transition period, the label of a medicine may contain the applicable advisory statements specified in Schedule 2 of the former specification instead of Schedule 1 to this instrument. However, once the transition period ceases, the label must contain the applicable advisory statements specified in Schedule 1.